Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Resorcinol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Resorcinol SCHEMBL8517218 | 1.00 | CA12 (0.92) | — | |
| Resorcinol SCHEMBL27800443 | 0.96 | CA12 (0.86) | — | |
| Resorcinol SCHEMBL326229 | 0.96 | CA12 (1.00) | — | |
| Resorcinol SCHEMBL15515 | 0.96 | — | — | |
| Resorcinol SCHEMBL11880713 | 0.92 | — | — | |
| Resorcinol SCHEMBL464804 | 0.92 | — | — | |
| Resorcinol SCHEMBL6842721 | 0.92 | — | — | |
| Resorcinol SCHEMBL1236660 | 0.92 | — | — | |
| Resorcinol SCHEMBL20577903 | 0.92 | — | — | |
| Resorcinol SCHEMBL7945602 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117510852-A | Ultraviolet-resistant modified PBO copolymer and application thereof | 山东非金属材料研究所 | 2024-02-06 | — | — | CN | claimed |
| CN-110172077-A | A kind of Chemoenzymatic synthesis method of the Monostalotetrahexosylgangliside of difference fat chain length | 武汉糖智药业有限公司 | 2019-08-27 | — | — | CN | claimed |
| CN-104119534-B | Polyhydroxy-p-phenylene benzodioxazole polymer and preparation and application thereof | 金宁人 | 2017-07-14 | — | — | CN | claimed |
| CN-104098589-B | 4- [6- (methylthio) benzo [1,2-d:5, 4-d' ] di [1,3] oxazole-2-yl ] benzoic acid and preparation method thereof | NANTONG UNIVERSITY (CN) | 2016-05-04 | — | — | CN | claimed |
| CN-1233695-C | Poly (phenylene benzozazole) and its prepolymer and their preparation method | UNIV BEIJING (CN) | 2005-12-28 | — | — | CN | claimed |
| CN-1517386-A | Poly (phenylene benzozazole) and its prepolymer and their preparation method | 北京大学 | 2004-08-04 | — | — | CN | claimed |
| US-4051314-A | FROM FUNGUS OF CLASS BASIDIOMYCETES, ANTICANCER AGENTS | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1977-09-27 | — | — | US | claimed |
| JP-1100456-A | — | — | None | — | — | JP | disclosed |
| CN-119504897-A | Non-sulfated monosialoganglioside and preparation method and application thereof | 大连海洋大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-119391683-A | Cellobiose epimerase mutant and application thereof | 合肥工业大学 | 2025-02-07 | — | — | CN | disclosed |
| CN-119120440-A | Glucose isomerase and method for improving activity of glucose isomerase | 湖南农业大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-115792048-B | Mass spectrum quantitative detection of standard characteristic polypeptide sequence of casein glycomacropeptide in polypeptide product | 无锡市食品安全检验检测中心 | 2024-11-05 | — | — | CN | disclosed |
| EP-4304631-B1 | TREATMENT OF EYE DISEASES WITH FRUCTOSYL-AMINO ACID OXIDASE | UNIV GENT (BE) | 2024-10-30 | — | — | EP | disclosed |
| EP-0295962-A2 | Protein-polysaccharide for treating retroviral infections | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-12-21 | — | — | EP | disclosed |
| EP-0295955-A2 | Lectins and antiretroviral drugs containing the lectins as active ingredients | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-12-21 | — | — | EP | disclosed |
| EP-0295961-A2 | Polysaccharides and antiviral drug containing polysaccharides as active ingredient | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-12-21 | — | — | EP | disclosed |
| EP-0295956-A2 | Use of a protein-bound polysaccharide for making a drug for treating AIDS. | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-12-21 | — | — | EP | disclosed |
| US-4507391-A | Method for detecting the presence of GD3 ganglioside | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1985-03-26 | — | — | US | disclosed |
| EP-0091005-A1 | Method for detecting the presence of GD3 ganglioside | Sloan-Kettering Institute For Cancer Research (US) | 1983-10-12 | — | — | EP | disclosed |
| US-4051314-A | FROM FUNGUS OF CLASS BASIDIOMYCETES, ANTICANCER AGENTS | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1977-09-27 | — | — | US | disclosed |